Diabetic patients should have a baseline eye examination around the time of GLP-1/GIP agonist treatment initiation to determine the level of retinopathy and presence of DME
But between work, social events, and enjoying the outdoors, its easy to feel run down
Aetnas typical PA requirements for Wegovy and Zepbound include: Documented BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea) Evidence of participation in a structured weight management program (diet, exercise, behavioral counseling) for a minimum period often 3 to 6 months Documentation that other weight loss interventions have been attempted Prescriber must be a physician, NP, or PA with appropriate prescribing authority Prior authorization is not a denial it is a documentation requirement
However, there were patients like Makowicki whose physicians prescribed them GLP-1s for weight loss who were able to obtain coverage through an apparent bureaucratic oversight by DSS
Table 2 gives an overview of the characteristics and results of the entire SURPASS study program (6974)
Usage recommendations
